Market Research Logo

Fina Biotech SL - Product Pipeline Analysis, 2018 Update

Summary

Fina Biotech SL (Fina), formerly Indas Biotech is a biotechnology projects developer that discovers new diagnostic and therapeutic techniques for the healthcare sector. The company finances, selects, develops, and markets biotechnology projects. It offers halosperm that is a kit to determine the degree of DNA fragmentation in human sperm. Fina also provides services to new tools for monitoring, diagnosis, prognosis and treatment of significant diseases and improve human health through the novelty carried out by Spanish researchers companies and research and development centers. The company’s research areas include molecular diagnostics and stem cell therapies. It provides investments in the areas of oncology, cardiology and stem cell therapy. The company collaborates with public and private institutions, medical universities, and diagnostic laboratories. Fina is headquartered in Madrid, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Fina Biotech SL
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Fina Biotech SL Company Overview
Fina Biotech SL Company Snapshot
Fina Biotech SL Pipeline Products and Ongoing Clinical Trials Overview
Fina Biotech SL – Pipeline Analysis Overview
Fina Biotech SL - Key Facts
Fina Biotech SL - Major Products and Services
Fina Biotech SL Pipeline Products by Development Stage
Fina Biotech SL Ongoing Clinical Trials by Trial Status
Fina Biotech SL Pipeline Products Overview
Dx Bioenergetic Signature - Breast Cancer
Dx Bioenergetic Signature - Breast Cancer Product Overview
Dx Bioenergetic Signature - Colon Cancer
Dx Bioenergetic Signature - Colon Cancer Product Overview
Dx Bioenergetic Signature - Lung Cancer
Dx Bioenergetic Signature - Lung Cancer Product Overview
Dx Bladder Cancer
Dx Bladder Cancer Product Overview
Dx Bladder Cancer Clinical Trial
Dx Colon Cancer
Dx Colon Cancer Product Overview
Dx Prostate Cancer
Dx Prostate Cancer Product Overview
Dx Restenosis
Dx Restenosis Product Overview
Fina Biotech SL - Key Competitors
Fina Biotech SL - Key Employees
Fina Biotech SL - Locations And Subsidiaries
Head Office
Recent Developments
Fina Biotech SL, Recent Developments
Jan 26, 2017: Fina Biotech Receives two new patents in 2015 in the United States and in Canada, both belonging to the patent family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”
Jan 26, 2016: Fina Biotech Receives Patents both in US and Canada
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Fina Biotech SL Pipeline Products and Ongoing Clinical Trials Overview
Fina Biotech SL Pipeline Products by Equipment Type
Fina Biotech SL Pipeline Products by Indication
Fina Biotech SL Ongoing Clinical Trials by Trial Status
Fina Biotech SL, Key Facts
Fina Biotech SL, Major Products and Services
Fina Biotech SL Number of Pipeline Products by Development Stage
Fina Biotech SL Pipeline Products Summary by Development Stage
Fina Biotech SL Ongoing Clinical Trials by Trial Status
Fina Biotech SL Ongoing Clinical Trials Summary
Dx Bioenergetic Signature - Breast Cancer - Product Status
Dx Bioenergetic Signature - Breast Cancer - Product Description
Dx Bioenergetic Signature - Colon Cancer - Product Status
Dx Bioenergetic Signature - Colon Cancer - Product Description
Dx Bioenergetic Signature - Lung Cancer - Product Status
Dx Bioenergetic Signature - Lung Cancer - Product Description
Dx Bladder Cancer - Product Status
Dx Bladder Cancer - Product Description
Dx Bladder Cancer - To evaluate the effectiveness of genetic markers in detection of bladder cancer.
Dx Colon Cancer - Product Status
Dx Colon Cancer - Product Description
Dx Prostate Cancer - Product Status
Dx Prostate Cancer - Product Description
Dx Restenosis - Product Status
Dx Restenosis - Product Description
Fina Biotech SL, Key Employees
Glossary
List of Figures
Fina Biotech SL Pipeline Products by Equipment Type
Fina Biotech SL Pipeline Products by Development Stage
Fina Biotech SL Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report